“Ceftolozane-Tazobatam for Febrile Neutropenia Treatment in Hematologic Malignancy Patients Colonized by Multi-Resistant Enterobacteriaceae: Preliminary Results from a Prospective Cohort Study: Ceftolozane-Tazobatam for Febrile Neutropenia”. (2020) 2020. Mediterranean Journal of Hematology and Infectious Diseases 12 (1): e2020065. https://doi.org/10.4084/mjhid.2020.065.